1
|
Jansana A, Comas M, Domingo L, Prados-Torres A, Gimeno-Miguel A, Poblador-Plou B, Castells X, Sala M. Multimorbidity patterns among long-term breast cancer survivors: a Spanish population-based study. Breast 2021. [DOI: 10.1016/s0960-9776(21)00241-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
2
|
Guerrero Fernández de Alba I, Gimeno-Miguel A, Poblador Plou B, Bliek Bueno K, Carmona Pirez J, Rodriguez-Blázquez C, Forjaz MJ, Prados-Torres A. Examining the impact of mental disease on type 2 diabetes outcomes: results from the EpiChron Cohort. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Type 2 diabetes mellitus (T2D) is often accompanied by other chronic diseases, including mental diseases (MD). This work aimed at studying MD prevalence in T2D patients and analyse its impact on T2D health outcomes.
Methods
Retrospective, observational study of individuals of the EpiChron Cohort aged 18 and over with prevalent T2D at baseline (2011) in Aragón, Spain (n = 63,365). Participants were categorized by the existence or absence of MD, defined as the presence of depression, anxiety, schizophrenia or substance abuse. MD prevalence was calculated, and a logistic regression model was performed to analyse the likelihood of the four studied health outcomes (4-year all-cause mortality, all-cause hospitalization, T2D-hospitalization, and emergency room visits) based on the presence of each type of MD, after adjusting by age, sex and number of comorbidities.
Results
Mental diseases were observed in 19% of T2D patients, with depression being the most frequent condition, especially in women (20.7% vs. 7.57%). Mortality risk was significantly higher in patients with MD (odds ratio -OR- 1.24; 95% confidence interval -CI- 1.16-1.31), especially in those with substance abuse (OR 2.18; 95% CI 1.84-2.57) and schizophrenia (OR 1.82; 95% CI 1.50-2.21). The presence of MD also increased the risk of T2D-hospitalization (OR 1.51; 95% CI 1.18-1.93), emergency room visits (OR 1.26; 95% CI 1.21-1.32) and all-cause hospitalization (OR 1.16; 95% CI 1.10-1.23).
Conclusions
The high prevalence of MD among T2D patients, and its association with health outcomes, underscores the importance of providing integrated, person-centred care and early detection of comorbid mental diseases in T2D patients to improve disease management and health outcomes.
Key messages
Comprehensive care of T2D should include specific strategies for prevention, early detection, and management of comorbidities, especially mental disorders, in order to reduce their impact on health. Substance abuse was the mental disease with the highest risk of T2D-hospitalization, emergency room visits and all-cause hospitalization.
Collapse
Affiliation(s)
- I Guerrero Fernández de Alba
- Teaching Unit of Preventive Medicine and Public Health, Miguel Servet University Hospital, Zaragoza, Spain
- EpiChron Research Group, IIS Aragón, Zaragoza, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| | - A Gimeno-Miguel
- EpiChron Research Group, IIS Aragón, Zaragoza, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| | - B Poblador Plou
- EpiChron Research Group, IIS Aragón, Zaragoza, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| | - K Bliek Bueno
- Teaching Unit of Preventive Medicine and Public Health, Miguel Servet University Hospital, Zaragoza, Spain
| | - J Carmona Pirez
- EpiChron Research Group, IIS Aragón, Zaragoza, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| | - C Rodriguez-Blázquez
- National Centre of Epidemiology, Carlos III Institute of Health, Madrid, Spain
- CIBERNED, Carlos III Institute of Health, Madrid, Spain
| | - M J Forjaz
- Department of Epidemiology and Biostatistics, Carlos III Institute of Health, Madrid, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| | - A Prados-Torres
- EpiChron Research Group, IIS Aragón, Zaragoza, Spain
- REDISSEC, Carlos III Institute of Health, Madrid, Spain
| |
Collapse
|
3
|
Prados-Torres A, Poblador-Plou B, Gimeno-Miguel A, Calderón-Larrañaga A, Poncel-Falcó A, Gimeno-Feliú LA, González-Rubio F, Laguna-Berna C, Marta-Moreno J, Clerencia-Sierra M, Aza-Pascual-Salcedo M, Bandrés-Liso AC, Coscollar-Santaliestra C, Pico-Soler V, Abad-Díez JM. Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study. Int J Epidemiol 2019; 47:382-384f. [PMID: 29346556 PMCID: PMC5913592 DOI: 10.1093/ije/dyx259] [Citation(s) in RCA: 50] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/15/2017] [Indexed: 12/21/2022] Open
Affiliation(s)
- A Prados-Torres
- EpiChron Research Group on Chronic Diseases: Aragon Health Sciences Institute (IACS), IIS Aragon, Miguel Servet University Hospital, Zaragoza, University of Zaragoza, Health Services Research on Chronic Patients Network (REDISSEC), Spain, JA-CHRODIS+, EU
| | - B Poblador-Plou
- IACS, IIS Aragon, Miguel Servet University Hospital, Zaragoza, REDISSEC, Spain
| | - A Gimeno-Miguel
- IACS, IIS Aragon, Miguel Servet University Hospital, Zaragoza, REDISSEC, Spain
| | - A Calderón-Larrañaga
- Aging Research Center, Karolinska Institutet, Stockholm, Sweden, REDISSEC, Spain
| | | | - L A Gimeno-Feliú
- Primary Care Health Centre (PCHC) San Pablo, Zaragoza, SALUD, University of Zaragoza, REDISSEC, Spain
| | | | - C Laguna-Berna
- IACS, IIS Aragon, Miguel Servet University Hospital, Zaragoza, REDISSEC, Spain
| | - J Marta-Moreno
- Miguel Servet University Hospital, Zaragoza, SALUD, REDISSEC, Spain
| | | | | | | | - C Coscollar-Santaliestra
- Primary Care Health Centre (PCHC) San Pablo, Zaragoza, SALUD, University of Zaragoza, REDISSEC, Spain
| | - V Pico-Soler
- PCHC Torrero-La Paz, Zaragoza, SALUD, REDISSEC, Spain
| | - J M Abad-Díez
- Aragon Health Service (SALUD), Department of Health, GRISSA Research Group, Spain
| |
Collapse
|